Patrick Chow

Title: The Innovative Contributions of Patrick Chow

Introduction

Patrick Chow is a notable inventor based in San Marino, California. He has made significant contributions to the field of medical devices, particularly in the development of steerable delivery systems for prosthetic applications. With a total of five patents to his name, Chow's work has the potential to improve patient outcomes in cardiac procedures.

Latest Patents

Chow's latest patents include a "Steerable delivery system for replacement mitral valve and methods of use." This invention describes devices, systems, and methods that enhance steerability for delivering a prosthesis to a specific body location, such as a replacement mitral valve. The delivery component features multiple slots that allow for desired bending, facilitating three-dimensional steering. Another significant patent is the "Steerable rail delivery system," which provides improved steerability for delivering prosthetic devices. This system includes a steerable rail designed for multi-plane bending, enabling precise direction of the delivery system's distal end.

Career Highlights

Throughout his career, Patrick Chow has worked with prominent companies in the medical device industry. He has been associated with Edwards Lifesciences and Cardiaq LLC, where he has contributed to the advancement of innovative medical technologies. His experience in these organizations has allowed him to refine his skills and focus on developing solutions that address critical healthcare challenges.

Collaborations

Chow has collaborated with notable professionals in his field, including Alexander H. Cooper and David Robert Landon. These partnerships have fostered an environment of innovation and have led to the successful development of groundbreaking medical devices.

Conclusion

Patrick Chow's contributions to the field of medical devices, particularly in steerable delivery systems, highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing technology that can significantly impact patient care.